Iron Deficiency Calculator
Calculate iron deficit and replacement dose from hemoglobin, weight, and target levels. Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateStandard: 500 mg for adults over 35 kg, 15 mg/kg for smaller patients
IV Iron Infusion Schedule Options
Formula
The Ganzoni formula calculates total iron deficit by multiplying body weight by the hemoglobin deficit and a conversion factor of 2.4 (which accounts for blood volume and iron content of hemoglobin), then adding iron stores (typically 500 mg for adults >35 kg). The simplified approach uses fixed doses based on weight and hemoglobin categories.
Last reviewed: January 2026
Worked Examples
Example 1: Iron Deficit Calculation Using Ganzoni Formula
Example 2: Simplified Dosing for CKD Patient
Background & Theory
The Iron Deficiency Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Iron Deficiency Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Sources & References
- 1Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100(7):301-303
- 2Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38
- 3Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843
Formula
Iron deficit (mg) = Weight(kg) x (Target Hb - Actual Hb)(g/dL) x 2.4 + Iron stores(mg)
The Ganzoni formula calculates total iron deficit by multiplying body weight by the hemoglobin deficit and a conversion factor of 2.4 (which accounts for blood volume and iron content of hemoglobin), then adding iron stores (typically 500 mg for adults >35 kg). The simplified approach uses fixed doses based on weight and hemoglobin categories.
Worked Examples
Example 1: Iron Deficit Calculation Using Ganzoni Formula
Problem: A 60 kg woman with iron deficiency anemia has a hemoglobin of 7.5 g/dL. Target hemoglobin is 12 g/dL. Calculate the total iron deficit using the Ganzoni formula with standard iron stores of 500 mg.
Solution: Ganzoni formula: Iron deficit = Weight x (Target Hb - Actual Hb) x 2.4 + Iron stores\nIron deficit = 60 kg x (12 - 7.5) g/dL x 2.4 + 500 mg\nIron for Hb correction = 60 x 4.5 x 2.4 = 648 mg\nIron for stores = 500 mg\nTotal iron deficit = 648 + 500 = 1,148 mg\nIron sucrose sessions (200 mg each): 6 sessions\nFerric carboxymaltose sessions (750 mg each): 2 sessions
Result: Total iron deficit: 1,148 mg - Requires 6 iron sucrose infusions or 2 ferric carboxymaltose infusions
Example 2: Simplified Dosing for CKD Patient
Problem: An 85 kg man with chronic kidney disease has hemoglobin of 9.2 g/dL and documented iron deficiency. Determine the appropriate iron replacement dose using the simplified approach.
Solution: Simplified dosing criteria:\nWeight: 85 kg (>=70 kg category)\nHemoglobin: 9.2 g/dL (<10 g/dL category)\nSimplified dose: 1,500 mg total\nFerric carboxymaltose: 2 sessions of 750 mg\nFerumoxytol: 3 sessions of 510 mg (1,530 mg total)\nIron dextran: 1 total dose infusion
Result: Simplified dose: 1,500 mg - Administer as 2 ferric carboxymaltose infusions or single iron dextran TDI
Frequently Asked Questions
What is the Ganzoni formula for calculating iron deficit?
The Ganzoni formula is the traditional and most widely used method for calculating total body iron deficit in patients with iron deficiency anemia. The formula is: Iron deficit (mg) = Body weight (kg) x (Target Hb - Actual Hb) (g/dL) x 2.4 + Iron stores (mg). The factor 2.4 is derived from the product of blood volume as a proportion of body weight (0.07 or 7%), the iron content of hemoglobin (0.0034 or 3.4 mg iron per gram of hemoglobin), and a unit conversion factor (1000). The iron stores component typically uses 500 mg for adults weighing more than 35 kg. This formula provides an individualized estimate that accounts for both the hemoglobin deficit and the need to replenish depleted iron stores.
What are the common intravenous iron formulations available?
Several intravenous iron formulations are available, each with different dosing schedules, administration rates, and safety profiles. Iron sucrose (Venofer) is administered in 200 mg doses over 15 minutes, requiring multiple sessions for full repletion. Ferric carboxymaltose (Injectafer) allows up to 750 mg per infusion in the US (1000 mg in Europe), often requiring only 1-2 sessions. Low-molecular-weight iron dextran (INFeD, CosmoFer) can deliver the total calculated dose in a single infusion over several hours. Ferumoxytol (Feraheme) is given as 510 mg infusions over 15 minutes, typically requiring 2-3 sessions. Ferric derisomaltose (Monoferric) can deliver up to 20 mg/kg in a single infusion. The choice depends on institutional availability, cost, patient convenience, and safety considerations.
When should intravenous iron be preferred over oral iron supplementation?
Intravenous iron is preferred over oral iron in several clinical scenarios where oral iron is insufficient, poorly tolerated, or clinically inappropriate. These include intolerance or non-compliance with oral iron (gastrointestinal side effects affect 30-50% of patients), malabsorption conditions such as celiac disease, inflammatory bowel disease, or post-bariatric surgery, chronic kidney disease especially in patients on dialysis, ongoing blood loss exceeding the absorption capacity of oral iron, severe iron deficiency anemia requiring rapid correction (hemoglobin below 7 g/dL), the second and third trimesters of pregnancy with significant anemia, and patients requiring erythropoiesis-stimulating agents who need adequate iron to support red blood cell production. IV iron achieves target hemoglobin levels faster than oral supplementation.
What laboratory tests confirm iron deficiency anemia?
The diagnosis of iron deficiency anemia requires a combination of laboratory tests that demonstrate both anemia and depleted iron stores. The complete blood count shows low hemoglobin and hematocrit, with microcytic (low MCV) and hypochromic (low MCH/MCHC) red blood cells. The red cell distribution width (RDW) is typically elevated, reflecting anisocytosis. Serum ferritin is the most specific test for iron stores, with levels below 30 ng/mL confirming iron deficiency (below 100 ng/mL in chronic kidney disease or inflammation). Serum iron is decreased while total iron-binding capacity (TIBC) is increased, resulting in a low transferrin saturation (below 20%). Soluble transferrin receptor levels are elevated. The reticulocyte hemoglobin content (CHr) below 28 pg is an early marker. The peripheral smear may show target cells, elliptocytes, and pencil cells.
What are the potential side effects and risks of intravenous iron?
Intravenous iron is generally safe but carries potential risks that clinicians must consider. Minor infusion reactions including flushing, urticaria, myalgias, chest tightness, and back pain occur in approximately 1-3% of infusions and usually respond to slowing the infusion rate. Serious anaphylactic or anaphylactoid reactions are rare, occurring in approximately 0.1% of modern formulations (significantly less than older high-molecular-weight iron dextran). Hypophosphatemia is a recently recognized complication, particularly with ferric carboxymaltose, which can cause phosphate wasting and rarely symptomatic hypophosphatemia. Extravasation can cause tissue staining. Long-term risks of iron overload exist if dosing exceeds actual deficit. Fishbane reactions (complement-activated pseudo-allergic reactions) can mimic true anaphylaxis but are generally self-limiting.
How should iron replacement be monitored after administration?
Monitoring after iron replacement therapy requires understanding the timeline of laboratory changes and appropriate test selection. Reticulocyte count typically increases within 5-7 days of adequate iron replacement, with peak reticulocytosis at 7-10 days. Hemoglobin begins rising within 2 weeks and should increase by approximately 1 g/dL every 2-3 weeks. Ferritin levels should be checked no sooner than 8-12 weeks after the last IV iron dose because ferritin is transiently elevated immediately after infusion and during acute phase responses. A target ferritin above 100 ng/mL and transferrin saturation above 20% indicates adequate repletion. If hemoglobin fails to respond as expected, clinicians should investigate ongoing blood loss, malabsorption, concurrent deficiencies (B12, folate), chronic disease, or incorrect diagnosis.
References
- Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100(7):301-303
- Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy